Evofem Biosciences Inc (NASDAQ:EVFM)

0.4119
Delayed Data
As of Jan 27
 -0.0117 / -2.76%
Today’s Change
0.36
Today|||52-Week Range
5.53
+9.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$69.3M

Company Description

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Contact Information

Evofem Biosciences, Inc.
12400 High Bluff Drive
San Diego California 92130
P:(858) 550-1900
Investor Relations:
18585501900167

Employees

Shareholders

Individual stakeholders9.54%
Mutual fund holders8.96%
Other institutional13.52%

Top Executives

Saundra L. PelletierPresident, Chief Executive Officer & Director
Richard M. MurawskiSenior Vice President-Operations
Justin J. FileChief Financial Officer
Brandi HowardHead-Medical Affairs
Kelly CulwellChief Medical Officer